FibroBiologics, Inc. (FBLG) Balance Sheet

NASDAQ: FBLGAssets, liabilities, debt and equity over 5 years.

FBLG balance sheet, FY2026

June 30, 2026 · U.S. dollars

$9.6M assets = $3.5M liabilities + $6.2M equity

Both columns are drawn to the same scale: what FBLG owns equals what it owes plus shareholders’ equity. Hover a block for its value.

FBLG financial health

Current ratio3.61

Comfortable · current assets cover current liabilities 3.61×

Debt / equity0.39

Low leverage · $0.39 of debt for each $1 of equity

Equity / assets64.0%

Equity-funded · of assets funded by shareholders

Cash / debt203.1%

Cash covers debt · cash & short-term investments vs total debt

Goodwill & intangibles0.0%

Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal FY2026.

FBLG balance sheet trends, FY2022–FY2026

FibroBiologics, Inc. balance sheet trends
Metric	Then	Latest	Change
Total assets	$468,000FY2022	$9.6MFY2026	+112.9%/yr
Total liabilities	$1.8MFY2022	$3.5MFY2026	+18.5%/yr
Shareholders’ equity	−$1.3MFY2022	$6.2MFY2026	—
Cash & short-term investments	$407,000FY2022	$4.9MFY2026	+86.2%/yr
Total debt	$1.3MFY2022	$2.4MFY2026	+16.7%/yr
Net cash (debt)	−$893,000FY2022	$2.5MFY2026	+$3.4M
Working capital	−$1.3MFY2022	$4.6MFY2026	+$5.9M
Book value per share	−$0.79FY2022	$2.76FY2026	—
Current ratio	0.27FY2022	3.61FY2026	+3.34
Debt / equity	1.39FY2024	0.39FY2026	−1.00
Shares outstanding	1.6MFY2022	2.2MFY2026	+8.3%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

FBLG assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

FBLG liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

FBLG debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

FBLG balance sheet

FibroBiologics, Inc. annual balance sheet
	FY2026	FY2025	FY2024	FY2023	FY2022
Assets
Cash & short-term investments	$4.9M	$14.0M	$9.2M	$2.3M	$407,000
Cash & equivalents	$4.9M	$14.0M	$9.2M	$2.3M	$407,000
Receivables	$0	$0	$0	$300,000	$0
Inventory	$0	$0	$0	$0	$0
Other current assets	$1.5M	$243,000	$52,000	$59,000	$61,000
Total current assets	$6.3M	$14.2M	$9.2M	$2.6M	$468,000
Property, plant & equipment (net)	$3.2M	$2.2M	$2.6M	$2.2M	$0
Goodwill & intangible assets	$0	$0	$0	$0	$0
Long-term investments	$0	$0	$0	$0	$0
Other non-current assets	$48,000	$0	$0	$0	$0
Total assets	$9.6M	$16.4M	$11.8M	$4.8M	$468,000
Liabilities
Accounts payable	$945,000	$2.7M	$1.4M	$758,000	$233,000
Short-term debt	$706,000	$9.6M	$362,000	$5.8M	$1.3M
Total current liabilities	$1.8M	$12.7M	$9.2M	$7.1M	$1.8M
Long-term debt	$0	$0	$0	$0	$0
Lease obligations	$2.4M	$1.4M	$1.7M	$2.1M	$0
Other long-term liabilities	$1.7M	$984,000	$1.4M	$1.7M	$0
Total liabilities	$3.5M	$13.7M	$10.6M	$8.8M	$1.8M
Shareholders' equity
Common stock & paid-in capital	$1,000	—	$1,000	$1,000	—
Retained earnings (deficit)	−$54.2M	−$35.5M	−$24.4M	−$7.9M	−$2.8M
Accumulated other comprehensive income	—	—	$0	$1.5M	$1.5M
Total shareholders' equity	$6.2M	$2.7M	$1.3M	−$4.0M	−$1.3M
Key figures
Total debt	$2.4M	$10.6M	$1.7M	$7.5M	$1.3M
Net cash (debt)	$2.5M	$3.4M	$7.4M	−$5.3M	−$893,000
Working capital	$4.6M	$1.5M	$32,000	−$4.4M	−$1.3M
Tangible book value	$6.2M	$2.7M	$1.3M	−$4.0M	−$1.3M
Book value per share	$2.76	$1.66	$0.77	−$2.46	−$0.79
Shares outstanding	2.2M	1.6M	1.6M	1.6M	1.6M
Current ratio	3.61	1.12	1.00	0.37	0.27
Quick ratio	2.78	1.10	1.00	0.36	0.23
Debt / equity	0.39	3.86	1.39	—	—
Equity / assets	64.0%	16.6%	10.6%	−82.8%	−275.6%

FibroBiologics, Inc. quarterly balance sheet
	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23
Assets
Cash & short-term investments	$3.5M	$1.5M	$4.9M	$4.9M	$8.8M	$8.7M	$14.0M	$7.8M	$6.0M	$8.2M	$9.2M	$10.8M
Cash & equivalents	$3.5M	$1.5M	$4.9M	$4.9M	$8.8M	$8.7M	$14.0M	$7.8M	$6.0M	$8.2M	$9.2M	$10.8M
Receivables	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other current assets	$2.3M	$1.4M	$1.5M	$373,000	$1.3M	$660,000	$243,000	$371,000	$536,000	$764,000	$52,000	$148,000
Total current assets	$5.8M	$2.9M	$6.3M	$5.2M	$10.2M	$9.3M	$14.2M	$8.2M	$6.5M	$8.9M	$9.2M	$10.9M
Property, plant & equipment (net)	$2.0M	$3.0M	$3.2M	$3.5M	$3.7M	$2.1M	$2.2M	$2.3M	$2.4M	$2.5M	$2.6M	$2.4M
Goodwill & intangible assets	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-term investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other non-current assets	$48,000	$48,000	$48,000	$48,000	$48,000	$0	$0	$0	$0	$0	$0	$0
Total assets	$7.9M	$5.9M	$9.6M	$8.7M	$13.9M	$11.4M	$16.4M	$10.5M	$8.9M	$11.4M	$11.8M	$13.3M
Liabilities
Accounts payable	$1.8M	$850,000	$945,000	$1.1M	$1.8M	$1.4M	$2.7M	$1.2M	$1.2M	$814,000	$1.4M	$820,000
Short-term debt	$382,000	$969,000	$706,000	$5.2M	$8.7M	$6.3M	$9.6M	$507,000	$669,000	$831,000	$362,000	$353,000
Total current liabilities	$2.2M	$1.8M	$1.8M	$6.7M	$11.0M	$8.2M	$12.7M	$6.7M	$10.1M	$14.0M	$9.2M	$1.3M
Long-term debt	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Lease obligations	$1.3M	$2.2M	$2.4M	$2.5M	$2.7M	$1.3M	$1.4M	$1.4M	$1.5M	$1.6M	$1.7M	$1.8M
Other long-term liabilities	$1.1M	$1.5M	$1.7M	$1.9M	$2.1M	$865,000	$984,000	$1.1M	$1.2M	$1.3M	$1.4M	$1.4M
Total liabilities	$3.3M	$3.3M	$3.5M	$8.6M	$13.0M	$9.1M	$13.7M	$7.7M	$11.3M	$15.3M	$10.6M	$2.8M
Shareholders' equity
Common stock & paid-in capital	$1,000	$1,000	$1,000	—	—	—	—	—	—	—	$1,000	$1,000
Retained earnings (deficit)	−$63.3M	−$59.2M	−$54.2M	−$50.9M	−$45.1M	−$40.5M	−$35.5M	−$32.4M	−$31.9M	−$32.8M	−$24.4M	−$14.6M
Total shareholders' equity	$4.6M	$2.6M	$6.2M	$125,000	$860,000	$2.4M	$2.7M	$2.7M	−$2.4M	−$3.9M	$1.3M	$10.5M
Key figures
Total debt	$1.5M	$2.5M	$2.4M	$7.1M	$10.8M	$7.1M	$10.6M	$1.6M	$1.8M	$2.1M	$1.7M	$1.8M
Net cash (debt)	$2.1M	−$996,000	$2.5M	−$2.2M	−$1.9M	$1.6M	$3.4M	$6.3M	$4.1M	$6.0M	$7.4M	$9.0M
Working capital	$3.6M	$1.1M	$4.6M	−$1.5M	−$786,000	$1.1M	$1.5M	$1.5M	−$3.6M	−$5.1M	$32,000	$9.6M
Tangible book value	$4.6M	$2.6M	$6.2M	$125,000	$860,000	$2.4M	$2.7M	$2.7M	−$2.4M	−$3.9M	$1.3M	$10.5M
Book value per share	$1.23	$0.69	$1.85	$0.06	$0.45	$1.28	$1.57	$1.63	−$1.46	−$2.48	$0.79	$6.49
Shares outstanding	3.8M	3.8M	3.3M	2.2M	1.9M	1.8M	1.7M	1.7M	1.6M	1.6M	1.6M	1.6M
Current ratio	2.64	1.59	3.61	0.78	0.93	1.14	1.12	1.23	0.64	0.64	1.00	8.31
Quick ratio	1.59	0.81	2.78	0.72	0.81	1.06	1.10	1.17	0.59	0.58	1.00	8.19
Debt / equity	0.32	0.95	0.39	56.90	12.53	3.03	3.86	0.57	—	—	1.39	0.17
Equity / assets	58.5%	43.8%	64.0%	1.4%	6.2%	20.6%	16.6%	26.1%	−26.8%	−33.9%	10.6%	79.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 24, 2026); data from EODHD.

FBLG financial position

At the end of fiscal 2026 (June 30, 2026), FibroBiologics had total assets of $9.6 million (down 41.5% from a year earlier), total liabilities of $3.5 million and shareholders' equity of $6.2 million. It held $4.9 million in cash and short-term investments against $2.4 million of debt, a net cash position of $2.5 million. Its current ratio was 3.61.

Related: FBLG income statement, FBLG cash flow statement, FBLG key metrics. See the FBLG stock overview for the latest quote and news.

FBLG balance sheet FAQ

What are FibroBiologics's total assets?

FibroBiologics reported total assets of $9.6 million at the end of fiscal 2026 (June 30, 2026), compared with $16.4 million a year earlier.

How much debt does FibroBiologics have?

FibroBiologics had $2.4 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.39.

How much cash does FibroBiologics have?

FibroBiologics held $4.9 million in cash and short-term investments at the end of fiscal 2026; with $2.4 million of debt that is net cash of $2.5 million.

What is FibroBiologics's book value?

FibroBiologics's shareholders' equity (book value) was $6.2 million at the end of fiscal 2026, or $2.76 per share.

What is FibroBiologics's current ratio?

FibroBiologics had current assets of $6.3 million and current liabilities of $1.8 million, a current ratio of 3.61 (it can cover its short-term obligations).